Ventilator-Associated Pneumonia
Preferred Treatment

Preferred Treatment

Preferred Treatment

+/-

  • Due to high local levels of resistance, tobramycin is recommended over fluoroquinolones as a second agent
  • Avoid gentamicin which lacks significant activity against P. aeruginosa

PLUS

Duration of Treatment

7 days for most patients (including MRSA HAP/VAP)

MRSA HAP/VAP with Bacteremia: 14 days

Patient Slow to Respond: Consider longer treatment course (i.e. 10-14 days)

Combination Therapy with Tobramycin: D/c tobramycin after 5 days